Bosh sahifaEXK • FRA
add
Exact Sciences Corp
Yopilish kursi
56,22 €
Kunlik diapazon
57,42 € - 57,42 €
Yillik diapazon
51,27 € - 94,79 €
Bozor kapitalizatsiyasi
11,41 mlrd USD
Oʻrtacha hajm
4,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2023info | Y/Y qiyosi |
|---|---|---|
Daromad | 646,88 mln | 16,98% |
Joriy xarajat | 552,23 mln | 6,14% |
Sof foyda | -49,77 mln | 61,04% |
Sof foyda marjasi | -7,69 | 66,71% |
Har bir ulushga tushum | -0,43 | 22,95% |
EBITDA | -23,04 mln | 64,54% |
Amaldagi soliq stavkasi | 1,21% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2023info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 777,64 mln | 23,03% |
Jami aktivlari | 6,47 mlrd | 3,93% |
Jami passivlari | 3,33 mlrd | 4,47% |
Umumiy kapital | 3,15 mlrd | — |
Tarqatilgan aksiyalar | 181,53 mln | — |
Narxi/balansdagi bahosi | 3,24 | — |
Aktivlardan daromad | -2,99% | — |
Kapitaldan daromad | -3,38% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2023info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -49,77 mln | 61,04% |
Operatsiyalardan naqd pul | 69,55 mln | 33,65% |
Sarmoyadan naqd pul | -66,77 mln | -14,80% |
Moliyadan naqd pul | 10,04 mln | -0,65% |
Naqd pulning sof oʻzgarishi | 14,77 mln | 105,45% |
Boʻsh pul | 60,81 mln | 271,11% |
Haqida
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer. Wikipedia
CEO
Tashkil etilgan
1-yan, 1995
Xodimlar soni
6 550
